Patent EP0003560A2 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0003560A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations

Assignee: Wellcome Foundation Ltd
•
Filing: 1979-01-31
•
Granted: —
•
Expires: 1999-01-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pharmaceutical formulations comprising an imidazole (or pharmaceutically acceptable salt thereof) of formula: wherein (i) A is an aliphatic hydrocarbon residue of from 1 to 4 carbon atoms and R is a naphthyl, tetrahydronaphthyl, heterocyclyl, arylthio, arylalkylthio, aryloxy, arylalkyloxy, arylhydroxymethylene, arylcarbonyl, arylalkylcarbonyl, alkyloxy, alkylthio or a substituted cycloalkyl or cycloalkenyl group or (ii) A is a -S0 2 - group and R is aryl or heterocyclyl or (iii) A is a chemical bond and R is a heterocyclyl or substituted phenyl group, or (iv) A is an aliphatic hydrocarbon residue of from 1 to 3 carbon atoms and R is a halophenyl group. Some of these imidazoles and salts are novel. Methods of preparing the imidazoles are disclosed. The imidazoles and their salts are useful in the treatment or prophylaxis of thrombo-embolic conditions.

Inventors

  • 👤 Peter Brian Thorogood

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-09 04:22
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/54; C07D233/56; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/41; A61K31/415; A61K31/435; A61K31/44; A61K31/445; A61K31/47; A61K31/485; A61K31/495; A61K31/505; A61K31/519; A61K31/52; A61K31/535; A61K31/55; A61P; A61P7/00; C07C; C07C17/00; C07C17/093; C07C17/16; C07D231/00; C07D231/02; C07D231/10; C07D231/12; C07D233/66; C07D233/84; C07D249/00; C07D249/02; C07D249/08; C07D319/00; C07D319/10; C07D319/14; C07D319/16; C07D319/20

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 145 words
A pharmaceutical formulation which comprises an imidazole of formula (IA) wherein (i) A is a straight or branched alkylene or alkepylene group having 1,2, 3 or 4 carbon, atoms, and R is a naphthyl, tetrahydronaphthyl, heterocyclyl, arylthio, arylalkylthio, aryloxy, arylalkyloxy, arylhydroxymethylene, arylcarbonyl, arylalkylcarbonyl, alkyloxy, alkylthio group or a cycloalkyl or cycloalkenyl group of from 4 to 9 carbon atoms suhstituted by a group other than a hydrocarbon group, (ii) A is an -SO 2 - group, and R is an aryl or heterocyclyl group, (iii) A is a chemical bond and R is a heterocyclyl or suhstituted phenyl group, or (iv) A is a straight or branched alkylene group having 1, 2 or 3 carbon atoms and R is a halo-substituted phenyl group; or a pharmaceutically acceptable acid addition salt of such an imidazole, and a pharmaceutically acceptable carrier for the imidazole or salt thereof.
Claim 2
Dependent Claim 145 words
A pharmaceutical formulation which comprises an imidazole of formula (IA) wherein (i) A is a straight or branched alkylene or alkepylene group having 1,2, 3 or 4 carbon, atoms, and R is a naphthyl, tetrahydronaphthyl, heterocyclyl, arylthio, arylalkylthio, aryloxy, arylalkyloxy, arylhydroxymethylene, arylcarbonyl, arylalkylcarbonyl, alkyloxy, alkylthio group or a cycloalkyl or cycloalkenyl group of from 4 to 9 carbon atoms suhstituted by a group other than a hydrocarbon group, (ii) A is an -SO 2 - group, and R is an aryl or heterocyclyl group, (iii) A is a chemical bond and R is a heterocyclyl or suhstituted phenyl group, or (iv) A is a straight or branched alkylene group having 1, 2 or 3 carbon atoms and R is a halo-substituted phenyl group; or a pharmaceutically acceptable acid addition salt of such an imidazole, and a pharmaceutically acceptable carrier for the imidazole or salt thereof.
Claim 3
Dependent Claim 28 words
A formulation according to claim 1 wherein, in the imidazole or salt thereof, the group R is substituted by one or more hydroxy, alkyloxy, halo or alkyl group.
Claim 4
Dependent Claim 29 words
A formulation according to claim 2 wherein, in the imidazole or salt thereof, the group R ia substituted by one or more hydroxy, methoxy, chloro, bromo or methyl group
Claim 5
Dependent Claim 19 words
A formulation according to any one of claims 1 to 3 in which A in formula (IA) is methylene.
Claim 6
Dependent Claim 30 words
A formulation according to claim 1 wherein the imidazole is selected from l-(l-naphthylmethyl )imidazole, 1-(2,3-dimethylphenyl)imidazole, 1-(2-bxomobenzyl) imidazole, 1-(3-bromobenzyl)imidazole, or 1-[3-(2,4-dichlorophenyl)propyl]imidazole or an acid addition . salt of one of these.
Claim 7
Dependent Claim 15 words
A formulation according to any one of claims 1 to 5 which is orally ingestible.
Claim 8
Dependent Claim 14 words
A formulation according to claim 6 in the form of a tablet or capsule.
Claim 9
Dependent Claim 22 words
A formulation according to any one of claims 1 to 5 in the form of a parenterally acceptable injectable solution or suspension.
Claim 10
Dependent Claim 20 words
A formulation according to claim 7 wherein the imidazole is present in an amount of from 50 to 600 mg.
Claim 11
Independent Claim 29 words
A method of preparing a pharmaceutical formulation according to any one of claims 1 to 9 which comprises admixing the imidazole or its salts with the pharmaceutically acceptable carrier.
Claim 12
Dependent Claim 211 words
A compound which is a 1-substituted imidazole of formula (1) wherein (i) A is a straight or branched alkylene or alkenylene group having 1,2,3 or 4 carbon atoms and R is selected from:- (a) a naphthyl group of formula when the two n's together are 0 or an integer of from 1 to 3, and the or each B which,when the two n's together are greater than 1, may be the same or different is halo, or alkyl or alkoxy of from 1 to 3 carbon atoms; (b) a tetrahydronaphthyl group; (c) a heterocyclyl group, with the proviso that when the heterocyclyl group is 2-pyridyl, 1-methylbenzimidazol-2-yl, 2 or 3-indolyl, 1-piperidinyl, or 1-morpholinyl, the group A has 3 or 4 carbon atoms; (d) an arylhydroxymethylene group; (e) an arylcarbonyl group; (f) an arylalkylcarbonyI group; (g) an alkyloxy group; (h) an alkylthio group; or (i)a cycloalkyl or cycloalkenyl group of from 4 to 9 carbon atoms substituted by a group other than a hydrocarbon group; or (ii) A is an-SO 2 -group, and R is an aryl group or a heterocyclyl group; (iii) A is a straight or branched alkylene group having 1, 2 or 3 carbon atoms and R is a halophenyl group; or an acid addition salt of such an imidazole.
Claim 13
Dependent Claim 211 words
A compound which is a 1-substituted imidazole of formula (1) wherein (i) A is a straight or branched alkylene or alkenylene group having 1,2,3 or 4 carbon atoms and R is selected from:- (a) a naphthyl group of formula when the two n's together are 0 or an integer of from 1 to 3, and the or each B which,when the two n's together are greater than 1, may be the same or different is halo, or alkyl or alkoxy of from 1 to 3 carbon atoms; (b) a tetrahydronaphthyl group; (c) a heterocyclyl group, with the proviso that when the heterocyclyl group is 2-pyridyl, 1-methylbenzimidazol-2-yl, 2 or 3-indolyl, 1-piperidinyl, or 1-morpholinyl, the group A has 3 or 4 carbon atoms; (d) an arylhydroxymethylene group; (e) an arylcarbonyl group; (f) an arylalkylcarbonyI group; (g) an alkyloxy group; (h) an alkylthio group; or (i)a cycloalkyl or cycloalkenyl group of from 4 to 9 carbon atoms substituted by a group other than a hydrocarbon group; or (ii) A is an-SO 2 -group, and R is an aryl group or a heterocyclyl group; (iii) A is a straight or branched alkylene group having 1, 2 or 3 carbon atoms and R is a halophenyl group; or an acid addition salt of such an imidazole.
Claim 14
Dependent Claim 22 words
A compound according to claim 11 wherein the group R is substituted by one or more hydroxy, alkyloxy, halo or alkyl group.
Claim 15
Dependent Claim 23 words
A compound according to claim 12 wherein the group R is substituted by one or more hydroxy, methoxy, chloro, bromo or methyl group.
Claim 16
Dependent Claim 15 words
A compound according to any one of claims 11 to 13 wherein A is methylene.
Claim 17
Dependent Claim 22 words
A compound according to claim 11 which is 1-(1-naphthylmethyl)imidazole, 1-(2-bxomobenzyl)imidazole, 1-(3-bromobenzyl)imidazole, 1-[3-(2,4-Dichlorophenyl) propyl]imidazole, or an acid addition salt of one of these.
Claim 18
Independent Claim 780 words
A method of preparing a 1-substituted imidazole of formula (I) as defined in any of claims 11 to 15 or an acid addition salt thereof characterised in that one (a) reacts imidazole or a salt thereof with an agent of the formula Z-A-R wherein A and R are defined in formula (I) and Z is a leaving group; (b) converts a substituted imidazole of the formula: wherein A and R are as defined in formula (I) and Q 1 , Q 2 and Q 3 etc. are the same or different, at least one being a radical capable of removal by reduction or oxidation, the other being a radical having the same or other removable function or is hydrogen, with the proviso that when R is, or includes, aryl or aromatic heterocyclyl, the removable groups Q etc may be, or may also be, on aryl or heterocyclyl ring(s) in R; (c) decarboxylates a carboxyimidazole derivative of the formula: wherein A and R are as defined in formula (I), one of R 1 , R 2 and R 4 is carboxyl or a derivative thereof, and the other is hydrogen, carboxyl or a derivative thereof with the proviso that, when R is, or includes, aryl or aromatic heterocyclyl, the removable groups R 1 , R 2 etc. may be, or may also be, on the aryl or heterocyclyl ring(s); (d) converts a precursor of the formula: wherein N is 1-imidazoline, 1-imidazole or 1-pyrazole, A is a straight or branched saturated or unsaturated acyclic hydrocarbon radical which may include a keto group and R 3 is as defined in formula (I), or provided that at least one of N, A and R 3 is other than 1-imidazole, a saturated acyclic hydrocarbon group and R of the product of formula (I); (e) alkylates or acylates a compound of formula (X): wherein A is as defined for formula (I) and R a is an aryl or aromatic heterocyclyl R(R being as defined for formula (I)) with a compound of formula QZ 1 wherein Q is an alkyl or acyl group and Z 1 is a leaving group; (f) cyclises a compound of formula (XI): wherein A and R are as defined for formula (I) and X 2 is a leaving group; (g) reacts a compound of formula (XII): wherein A and R are as defined for formula (I) with a compound of formula (XIII): wherein either of X 3 and Y 3 is a leaving group and the other is hydrogen, or X 3 and Y 3 are both halo or, together with the CH group to which they are attached form an aldehyde group or an acetal derivative thereof, and X 4 and Y 4 are as defined for X 3 and y3 , being the same as or different from X 3 and Y 3 ; or (h) reduces an amino salt of formula (XIIIa): wherein R is defined as for formula (I), X is an anion, A 2 is a chemical bond or a straight or branching, saturated or unsaturated acyclic hydrocarbon radical, which may include a keto group, A3 is hydrogen or a saturated or unsaturated acyclic hydrocarbon radical, which may include a keto group, with the proviso that A 2 and A3 together contain no more than 3 carbon atoms; (i) reacts a compound in which R as defined for formula (I) is replaced by a cycloalkenyl or cycloalkynyl group containing one or more carbon to carbon double or triple bonds with an electrophilic reagent capable of adding across the double or triple bond(s) so as to provide the substituents in the cycloalkyl or cycloalkenyl ring of the compound of formula (I); (j) when R is heterocyclyl reacts imidazole with an aldehyde and a heterocyclyl compound containing an -NH-group in the heterocyclyl ring(s). (k) reacts imidazole with a Mannich base which may be prepared from (i) an aldehyde A 4 C HO, wherein A4 is hydrogen or contains less carbon atom than A as defined for formula (I), (ii) a heterocyclyl compound RH, R being a heterocyclyl group as defined for formula (I) to which the hydrogen atom is attached to form a ring -NH-group and (iii) a cyclic or acyclic secondary amine or (1) reacts a heterocyclyl compound RH, R being a heterocyclyl group as defined for formula (I) to which the hydrogen atom is attached to form a ring -NH-group, with a Mannich base which may be prepared from (i) an aldehyde A 4 CHO, wherein A 4 is hydrogen or contains 1 less carbon atom than A as defined for formula (I) , (ii) imidazole and (iii) a cyclic or acyclic secondary amine (other than RH).
Claim 19
Dependent Claim 23 words
A formulation according to any one of claims 1 to 9 for the treatment or prophylaxis of a thromboembolic condition in a mammal.
Claim 20
Dependent Claim 27 words
A formulation according to any one of claims 1 to 9 for treating myocardial infarction, cerebrovascular thrombosis, ischaemic peripheral vascular disease or post-operative thrombosis in a mammal.
Claim 21
Dependent Claim 23 words
A compound according to any one of claims 11 to 16 for the treatment or prophylaxis of a thromboembolic condition in a mammal.
Claim 22
Dependent Claim 27 words
A compound according to any one of claims 11 to 16 for treating myocardial infarction cerebrovascular thrombosis, ischaemic peripheral vascular disease or post-operative thrombosis in a mammal.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag